LCMT1 and prostate carcinoma: Analysis of the TCGA prostate dataset revealed no significant change in the expression of LCMT1 mRNA or any mutation in its coding sequence or genomic deletion in primary prostate cancer and benign prostate tissue (Supplementary Fig. 6a).